Pelthos Therapeutics Inc.
AMEXPTHS cost to borrow surges to 1.57%, up 295% over one week as short sellers face higher borrowing costs on the biotech name.
Snapshot as of 28 Jun 2026
No long-form analysis yet for PTHS. Pulse alerts and the live data picture are available on ORTEX.
Open PTHS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PTHS — free to start on ORTEX.
Sign up for free →Open PTHS on ORTEX